ABBOTINDIA Aperçu des actions
Abbott India Limited, avec ses filiales, est une entreprise pharmaceutique en Inde. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 0/6 |
| Croissance future | 3/6 |
| Performances passées | 5/6 |
| Santé financière | 6/6 |
| Dividendes | 5/6 |
Abbott India Limited Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | ₹27,378.30 |
| Plus haut sur 52 semaines | ₹30,521.00 |
| Plus bas sur 52 semaines | ₹22,000.00 |
| Bêta | 0.013 |
| 1Variation sur 1 mois | -3.84% |
| Variation sur 3 mois | -9.33% |
| Variation sur 1 an | 15.01% |
| 3Variation sur 3 ans | 44.06% |
| Variation sur 5 ans | 114.35% |
| Évolution depuis l'introduction en bourse | 3,469.53% |
Nouvelles et mises à jour récentes
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Recent updates
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00
Jul 13Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jun 27Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 13Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year
May 12Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price
Jan 07Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jul 15Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00
Jul 01Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00
May 22With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case
Apr 14Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?
Dec 31We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching
Jan 28A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)
Dec 05Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?
Oct 30Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?
Jul 16How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?
Mar 24The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It
Mar 03Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 04How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?
Jan 14
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why
Dec 24Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years
Dec 03Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?
Nov 12Rendement pour les actionnaires
| ABBOTINDIA | IN Pharmaceuticals | IN Marché | |
|---|---|---|---|
| 7D | 1.0% | 0.8% | 2.9% |
| 1Y | 15.0% | 42.1% | 28.9% |
Rendement vs Industrie: ABBOTINDIA a sous-performé le secteur Indian Pharmaceuticals qui a rapporté 42.1 % au cours de l'année écoulée.
Rendement vs marché: ABBOTINDIA a sous-performé le marché Indian qui a rapporté 28.9 % au cours de l'année écoulée.
Volatilité des prix
| ABBOTINDIA volatility | |
|---|---|
| ABBOTINDIA Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.0% |
Cours de l'action stable: ABBOTINDIA n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de ABBOTINDIA ( 3% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1910 | 3,814 | Swati Dalal | www.abbott.co.in |
Abbott India Limited, avec ses filiales, est une entreprise pharmaceutique en Inde. L'entreprise propose des produits pharmaceutiques pour la gastro-entérologie, la santé des femmes, le métabolisme, le système nerveux central, les vaccins et les spécialités multiples, notamment l'insomnie, la carence en vitamine D, l'accouchement prématuré et la gestion de la douleur. Elle fournit des produits anti-infectieux, cardio-diabétiques, hépatologiques, hormonaux, neuro-psychiatriques, hépatiques, gennext et de consommation.
Abbott India Limited Résumé des fondamentaux
| ABBOTINDIA statistiques fondamentales | |
|---|---|
| Capitalisation boursière | ₹584.47b |
| Bénéfices(TTM) | ₹12.85b |
| Recettes(TTM) | ₹60.66b |
45.3x
Ratio P/E9.6x
Ratio P/SLe site ABBOTINDIA est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| ABBOTINDIA compte de résultat (TTM) | |
|---|---|
| Recettes | ₹60.66b |
| Coût des recettes | ₹33.43b |
| Marge brute | ₹27.23b |
| Autres dépenses | ₹14.39b |
| Les revenus | ₹12.85b |
Derniers bénéfices déclarés
Sep 30, 2024
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 604.57 |
| Marge brute | 44.89% |
| Marge bénéficiaire nette | 21.18% |
| Ratio dettes/capitaux propres | 0% |
Quelles ont été les performances à long terme de ABBOTINDIA?
Voir les performances historiques et les comparaisons